日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Unraveling the role of the solute carrier family in hepatocellular carcinoma: mechanisms and therapeutic prospects

揭示溶质载体家族在肝细胞癌中的作用:机制和治疗前景

Xue, Yi; Yang, Xuanran; Zhang, Chi; Li, Huan; Zeng, Chuanfei; Chen, Mingkai

The Role of Solute Carrier Family Transporters in Hepatic Steatosis and Hepatic Fibrosis

溶质载体家族转运蛋白在肝脂肪变性和肝纤维化中的作用

Zhang, Chi; Yang, Xuanran; Xue, Yi; Li, Huan; Zeng, Chuanfei; Chen, Mingkai

Causal Effects of Sleep Traits on Angina Pectoris: Mediation by Cardiovascular Risk Factors

睡眠特征对心绞痛的因果效应:心血管危险因素的中介作用

Zeng, Chuanfei; Ke, Yujia; Li, Huan; Zhang, Chi; Chen, Jian; Chen, Mingkai

Development and validation of a pathological model predicting the efficacy of neoadjuvant therapy for breast cancer based on RCB scoring

基于RCB评分的乳腺癌新辅助治疗疗效预测病理模型的开发与验证

Li, Huan; Ju, Xianli; Zeng, Chuanfei; Chen, Zhengzhuo; Yu, LinXin; Ke, Ge; Huang, Ziyin; Wang, Youping; Yuan, Jingping; Chen, Mingkai

Identification of IL-34 and Slc7al as potential key regulators in MASLD progression through epigenomic profiling.

通过表观基因组分析鉴定 IL-34 和 Slc7al 为 MASLD 进展中的潜在关键调节因子

Zeng Chuanfei, Wei Mingliang, Li Huan, Yu Linxin, Wang Chuang, Mu Ziqi, Huang Ziyin, Ke Yujia, Li Lian-Yun, Xiao Yong, Wu Min, Chen Ming-Kai

The prognostic model of low-grade glioma based on m6A-associated immune genes and functional study of FBXO4 in the tumor microenvironment

基于m6A相关免疫基因的低级别胶质瘤预后模型及FBXO4在肿瘤微环境中的功能研究

Zhang, Yiling; Luo, Na; Li, Xiaoyu; Zeng, Chuanfei; Chen, Xin; Peng, Xiaohong; Zhang, Yuanyuan; Hu, Guangyuan

The Role of Interferon Regulatory Factors in Liver Diseases

干扰素调节因子在肝脏疾病中的作用

Zeng, Chuanfei; Zhu, Xiaoqin; Li, Huan; Huang, Ziyin; Chen, Mingkai

Non-specific electrocardiographic ST-T abnormalities predict mortality in patients on peritoneal dialysis

非特异性心电图ST-T异常可预测腹膜透析患者的死亡率

Zhan, Xiaojiang; Zeng, Chuanfei; He, Jiajing; Wang, Menghui; Xiao, Jun

Systematic Review and Pharmacological Considerations for Chloroquine and Its Analogs in the Treatment for COVID-19

氯喹及其类似物治疗COVID-19的系统评价和药理学考量

Peng, Hongwei; Chen, Zhangren; Wang, Yunyun; Ren, Simei; Xu, Tiantian; Lai, Xin; Wen, Jinhua; Zhao, Mengjun; Zeng, Chuanfei; Du, Lijuan; Zhang, Yanmei; Cao, Li; Hu, Jinfang; Wei, Xiaohua; Hong, Tao